Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin sensitisation: in vitro
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
an in vitro skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study are available
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Data provided by ECHA on request of Cytec Surface Specialties NV/SA. SNIF last update on 1993-10-25, UUID: SNIF-a53a2718-53ed-33b4-b9a3-440eef4897f2
Qualifier:
according to guideline
Guideline:
other: 92/69/EEC (Magnusson and Kligman)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The study was conducted before the requirement for LLNA as a basic study to perform was mandated in 2013.
Species:
guinea pig
Strain:
other: Pirbright-White
Sex:
not specified
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: not stated
- Age at study initiation: not stated
- Weight at study initiation: not stated
- Housing: not stated
- Diet (e.g. ad libitum): not stated
- Water (e.g. ad libitum): not stated
- Acclimation period: not stated


ENVIRONMENTAL CONDITIONS
- Temperature (°C): not stated
- Humidity (%): not stated
- Air changes (per hr): not stated
- Photoperiod (hrs dark / hrs light):not stated
Route:
intradermal
Vehicle:
other: semi-liquid paraffin
Concentration / amount:
Concentration of test material and vehicle used at induction:
a). Intradermal 5% in semi-liquid paraffin
b). Topical 100%

Concentration of test material and vehicle used for each challenge:
a). 100%
Route:
epicutaneous, open
Vehicle:
other: semi-liquid paraffin
Concentration / amount:
Concentration of test material and vehicle used at induction:
a). Intradermal 5% in semi-liquid paraffin
b). Topical 100%

Concentration of test material and vehicle used for each challenge:
a). 100%
No. of animals per dose:
Number of animals in test group: 10
Number of animals in control group: 5
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
100%
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
100%
No. with + reactions:
4
Total no. in group:
10
Key result
Reading:
rechallenge
Hours after challenge:
24
Group:
test chemical
Dose level:
100%
No. with + reactions:
6
Total no. in group:
10
Key result
Reading:
rechallenge
Hours after challenge:
48
Group:
test chemical
Dose level:
100%
No. with + reactions:
8
Total no. in group:
10
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
100%
No. with + reactions:
0
Total no. in group:
5
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
100%
No. with + reactions:
0
Total no. in group:
5
Key result
Reading:
rechallenge
Hours after challenge:
24
Group:
negative control
Dose level:
100%
No. with + reactions:
0
Total no. in group:
5
Key result
Reading:
rechallenge
Hours after challenge:
48
Group:
negative control
Dose level:
100%
No. with + reactions:
0
Total no. in group:
5
Key result
Group:
positive control
Remarks on result:
not measured/tested

Maximum concentration not causing irritating effect in a preliminary test was 100%.

Signs of irritation during induction: slight erythema was observed at application sites, treated with the vehicle alone, for up to 3 days and at sites treated with the test substance in vehicle, up to 5 days after application.

Evidence of sensitisation for each challenge concentration:

- 1st challenge: 4 out of 10,

- 2nd challenge: 8 out of 10

Interpretation of results:
sensitising
Conclusions:
Under the study conditions, the test substance was sensitising to guinea pig skin.
Executive summary:

A study was conducted to determine skin sensitization potential of the test substance to guinea pig according to the method described in EC Regulation 92/69/EEC. Pirbright white guinea pigs were used in the skin sensitisation study. The concentration of the test substance and vehicle tested in the induction and challenge was 5% in semi-liquid paraffin. Intradermal injections of the test substance caused well defined erythema and slight oedema at the test sites of more than 30% animals. Under the study conditions, the test substance was sensitising to guinea pig skin (Anonymous, 1993).

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

A study was conducted to determine skin sensitization potential of the test substance to guinea pig according to the method described in EC Regulation 92/69/EEC. Pirbright white guinea pigs were used in the skin sensitisation study. The concentration of the test substance and vehicle tested in the induction and challenge was 5% in semi-liquid paraffin. Intradermal injections of the test substance caused well defined erythema and slight oedema at the test sites of more than 30% animals. Under the study conditions, the test substance was sensitising to guinea pig skin (Anonymous, 1993).

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on an in vivo skin sensitisation study, the test substance warrants a classification of Skin Sens 1B (H317: May cause an allergic skin reaction) according to EU CLP (EC 1272/2008) criteria.

.